Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myocardial Fibrosis: early-phase trial registry
2 of 5 indexed Myocardial Fibrosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Myocardial Fibrosis: 5 US clinical trials tracked, 2 recruiting.
Myocardial Fibrosis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Thomas Hope, running 1 of these trials.
Enrollment posture brief
Registry condition myocardial-fibrosis
OPEN 2 | RECR 40% | LATE 1 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Myocardial Fibrosis lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myocardial Fibrosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myocardial Fibrosis is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Myocardial Fibrosis research.
Thomas Hope accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Myocardial Fibrosis trials plan to enrol fewer than 100 people.
Median target enrolment is 25 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Myocardial Fibrosis research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Weill Medical College of Cornell University
NCT05302271
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
Johns Hopkins University
NCT05954559
Ultrahypofractionation and Normal Tissue Toxicity
Massachusetts General Hospital
NCT05912231
Noninvasive Imaging of Heart Failure: A Pilot Study
National Institutes of Health Clinical Center (CC)
NCT01160471
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
Thomas Hope
NCT05180162
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Myocardial Fibrosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myocardial Fibrosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myocardial Fibrosis page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Myocardial Fibrosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Thomas Hope sponsors the most Myocardial Fibrosis trials on record, review their full trial history before evaluating a specific study. See Thomas Hope's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myocardial Fibrosis condition card totals 5 registered trials; most-linked intervention Accelerated Photon Radiation Therapy (XRT); top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.